Clinical Focus


  • Vascular Surgery
  • Endovascular procedures
  • Carotid disease
  • Aortic aneurysm
  • Peripheral arterial disease

Academic Appointments


Professional Education


  • Board Certification: Vascular Surgery, American Board of Surgery (2014)
  • Board Certification, American Board of Surgery, Vascular Surgery (2014)
  • Fellowship:University of Tennessee (2013) TNUnited States of America
  • Residency:East Tennessee State University Medicine (2011) TN
  • Medical Education:Armed Forces Medical College (2003) India

All Publications


  • Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ (Clinical research ed.) Prasad, K., Siemieniuk, R., Hao, Q., Guyatt, G., O'Donnell, M., Lytvyn, L., Heen, A. F., Agoritsas, T., Vandvik, P. O., Gorthi, S. P., Fisch, L., Jusufovic, M., Muller, J., Booth, B., Horton, E., Fraiz, A., Siemieniuk, J., Fobuzi, A. C., Katragunta, N., Rochwerg, B. 2018; 363: k5130

    Abstract

    WHAT IS THE ROLE OF DUAL ANTIPLATELET THERAPY AFTER HIGH RISK TRANSIENT ISCHAEMIC ATTACK OR MINOR STROKE? SPECIFICALLY, DOES DUAL ANTIPLATELET THERAPY WITH A COMBINATION OF ASPIRIN AND CLOPIDOGREL LEAD TO A GREATER REDUCTION IN RECURRENT STROKE AND DEATH OVER THE USE OF ASPIRIN ALONE WHEN GIVEN IN THE FIRST 24 HOURS AFTER A HIGH RISK TRANSIENT ISCHAEMIC ATTACK OR MINOR ISCHAEMIC STROKE? AN EXPERT PANEL PRODUCED A STRONG RECOMMENDATION FOR INITIATING DUAL ANTIPLATELET THERAPY WITHIN 24 HOURS OF THE ONSET OF SYMPTOMS, AND FOR CONTINUING IT FOR 10-21 DAYS CURRENT PRACTICE IS TYPICALLY TO USE A SINGLE DRUG.

    View details for PubMedID 30563885